|[November 01, 2013]
Law Offices of Todd M. Garber Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Edwards Lifesciences Corporation
LOS ANGELES --(Business Wire)--
The Law Offices of Todd M. Garber
announces that all purchasers of the common stock of Edwards
Lifesciences Corporation ("Edwards Lifesciences" or the "Company")
(NYSE:EW) between April 25, 2012 and April 23, 2013, inclusive (the
"Class Period') have until November 18, 2013, to file a motion to be
appointed as lead plaintiff in the shareholder lawsuit filed in the
United States District Court for the Central District of California.
Edwards Lifesciences is a medical device maker that designs and markets,
among other things, artificial heart valves for implantation in patients
with advanced cardiovascular disease. The Company's SAPIEN line of
transcatheter heart valves may be implanted using a minimally invasive
The Complaint alleges that the Company issued false and/or misleading
statements and failed to disclose material facts related to the
prospects, projected sales and adoption of the Company's Edwards SAPIEN
transcatheter aortic heart valve, including the related transfemoral and
transapical delivery methods ("SAPIEN"), and related projections of
financial performance for the Company's operations. Specifically, the
Complaint alleges that the defendants knew but concealed from Edwards
Lifesciences' shareholders during the Class Period that:
Adoption of SAPIEN was weaker than the Company claimed, due to
concerns among physicians over the risks and complexity of the
procedure for implanting the valve.
Edwards Lifesciences' outlook for sales and earnings per share was
significantly weaker than the optimistic guidance defendants offered
Defendants lacked a reasonable basis for the statements made
concerning the Company's operations, forecasts and outlook.
If you are a member of the above-described Class, you may move the Court
no later than November 18, 2013 to serve as lead plaintiff; however, you
must meet certain legal requirements. To be a member of the Class, you
may retain counsel of your choice or take no action and remain an absent
member of the Class. If you have information or would like to learn more
about these claims, or if you purchased Edwards Lifesciences shares
before the Class Period, and have any questions concerning this
announcement or your rights or interests with respect to these matters,
please contact Todd M. Garber, Esquire, of the Law Offices of Todd M.
Garber, by telephone at 213-700-7262 or by email to email@example.com.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
[ Back To Technology News's Homepage ]